Related Experiment Video
Updated: Mar 28, 2026

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
Published on: March 1, 2022
ATM functions as a rheostat of metabolic stress in small-cell lung cancer
Debdatta Halder1, Utsav Sen1, Vrinda Jethalia1,2,3
1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
ATM is best known as a guardian of genomic stability, yet its contributions to oncogenic signaling in aggressive malignancies like small-cell lung cancer (SCLC) remain poorly understood. Despite ATM being an established clinical vulnerability in SCLC, its influence on dysregulated tumorigenic circuits remains unclear. We demonstrate that inhibition of ATM disrupts the AKT-mTORC1-4EBP1 signaling axis, leading to attenuation of the master regulator of stress, ATF4. ATF4 and MYC appear to co-regulate one another in a feedback loop critical for redox homeostasis. ATM inhibition perturbs both the expression and function of MYC and ATF4, leading to increased intracellular reactive oxygen species, impaired glutathione recycling, and ferroptotic cell death, thereby exposing a crucial dependency of SCLC on stress-adaptive signaling. We uncover previously unrecognized metabolic vulnerability in SCLC, nominating ATM as a regulator of adaptive stress, expanding its role beyond canonical DNA damage repair (DDR) and highlighting therapeutically exploitable opportunities in aggressive tumors.
Insights
ATM inhibition disrupts stress-adaptive signaling in small-cell lung cancer (SCLC), leading to ferroptosis. This reveals a new metabolic vulnerability and therapeutic target beyond DNA damage repair in aggressive tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- ATM is crucial for genomic stability but its role in SCLC oncogenic signaling is unclear.
- SCLC's metabolic landscape and interaction with signaling networks are poorly understood, hindering treatment strategies.
Purpose of the Study:
- To investigate ATM's role in SCLC oncogenic signaling and metabolic adaptation.
- To identify novel therapeutic vulnerabilities in SCLC by understanding ATM's function beyond DNA damage repair.
Main Methods:
- Inhibition of ATM in SCLC models.
- Analysis of AKT-mTORC1-4EBP1 signaling axis and ATF4/MYC feedback loop.
- Assessment of reactive oxygen species, glutathione recycling, and ferroptosis.
Main Results:
- ATM inhibition disrupts the AKT-mTORC1-4EBP1 axis and attenuates ATF4.
- ATM inhibition perturbs ATF4 and MYC co-regulation, impacting redox homeostasis.
- ATM inhibition increases ROS, impairs glutathione recycling, and induces ferroptosis in SCLC cells.
Conclusions:
- ATM regulates adaptive stress responses and metabolic rewiring in SCLC, expanding its known functions.
- ATM inhibition exposes a critical dependency of SCLC on stress-adaptive signaling, offering therapeutic opportunities.
- Targeting ATM presents a novel strategy for aggressive SCLC by exploiting its metabolic vulnerabilities.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
ATP Synthase: Structure

